GLAXOCHEM (UK) UNLIMITED - Profile & Financials

Accounts Submitted 28 May 2025

Confirmation Statement Submitted 13 Aug 2025

Net assets £2655.07M £99.41M 2024 year on year

Total assets £2693.31M £105.75M 2024 year on year

Total Liabilities £38.24M £6.34M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover GLAXOCHEM (UK) UNLIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

N/A

Net Assets

£2655.07M

Increased by £99.41M (+4%)

Total Liabilities

£38.24M

Increased by £6.34M (+20%)

Turnover

N/A

Employees

N/A

Debt Ratio

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 7 resigned

Show resigned officers

						Status
Alistair Robert Davidson	Director	British	England	53	17 Sept 2020	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	4 Oct 2001	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	4 Oct 2001	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	4 Oct 2001	Active

Shareholders

Shareholders (4)


Glaxosmithkline Sl Lp	20.3%	925,744,482	Ordinary	17 Sept 2020
Setfirst Limited	16.6%	756,075,935	Ordinary C	17 Sept 2020
Setfirst Limited	11.8%	539,745,855	Ordinary B	17 Sept 2020

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Setfirst Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors

Glaxosmithkline Finance Plc

Ceased 29 Aug 2019

Ceased

See All Controllers

Group Structure

SETFIRST LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GLAXOCHEM (UK) UNLIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
13 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-08-13 with no updates	View(3 pages)
13 Aug 2025	Confirmation Statement	Second Filing Of Confirmation Statement With Made Up Date	View(3 pages)
28 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(11 pages)
28 May 2025	Other	Notice of agreement to exemption from audit of accounts for period ending 31/12/24	View(1 page)
28 May 2025	Other	Audit exemption statement of guarantee by parent company for period ending 31/12/24	View(2 pages)